Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in a Cystic Fibrosis Child With L1077P Mutation

被引：0

作者：

Sepe, Angela ^{[1
]}

Castaldo, Alice ^{[2
,3
]}

Cimbalo, Chiara ^{[4
]}

Villella, Valeria R. ^{[5
]}

Amato, Felice ^{[5
,6
]}

Buonpensiero, Paolo ^{[1
]}

Di Pasqua, Antonio ^{[1
]}

Salvadori, Laura ^{[1
]}

Polizzi, Sara ^{[1
]}

Arnone, Maria T. ^{[1
]}

Di Lullo, Antonella M. ^{[5
,6
,7
]}

Raia, Valeria ^{[4
]}

Tosco, Antonella ^{[1
]}

机构：

[1] Cyst Fibrosis Reg Reference Ctr AOU Federico II, Dept Maternal & Child Hlth, Paediat Unit, Naples, Italy

[2] AORN SantobonoPausilipon, SC Pneumol & UTSIR, Naples, Italy

[3] Univ Napoli Federico II, Dipartimento Sanita Pubbl, Naples, Italy

[4] Federico II Univ Naples, Reg Cyst Fibrosis Ctr, Dept Translat Med Sci, Sect Pediat, Naples, Italy

[5] CEINGE Adv Biotechnol Franco Salvatore, Naples, Italy

[6] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy

[7] Univ Campania Luigi Vanvitelli, Dept Mental & Phys Hlth & Prevent, Otorhinolaryngol Head & Neck Surg Unit, Med, Naples, Italy

来源：

PEDIATRIC PULMONOLOGY | 2025年 / 60卷 / 02期

关键词：

D O I：

10.1002/ppul.27510

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

引用

页数：3

共 50 条

[1] Elexacaftor/Tezacaftor/Ivacaftor (Trikafta) for Cystic Fibrosis
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2020, 62 (1589): : 5 - 7
[2] Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Advanced Cystic Fibrosis Lung Disease
Djavid, Amir Reza
Thompson, Alison E.
Irace, Alexandria L.
Gusman, Elen
Altman, Kimberly
DiMango, Emily A.
Keating, Claire L.
ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (11) : 1924 - 1927
[3] Efficacy of Elexacaftor-Tezacaftor-Ivacaftor on chronic rhinosinusitis in cystic fibrosis
Di Gioia, Stefano
Lucca, Francesca
Venditto, Laura
Sandri, Giulio
Tommasi, Nicola
Cipolli, Marco
Molteni, Gabriele
AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2024, 45 (03)
[4] Cystic Fibrosis: Triple Therapy with Elexacaftor, Tezacaftor and Ivacaftor
Lorenz, Judith
PNEUMOLOGIE, 2022, 76 (03): : 153 - 153
[5] Tolerance of elexacaftor/tezacaftor/ivacaftor in Australians with cystic fibrosis
Ruseckaite, Rasa
Wark, Peter
Pourghaderi, Ahmadreza
Caruso, Marisa
Ahern, Susannah
RESPIROLOGY, 2024, 29 : 8 - 8
[6] The efficacy of Elexacaftor/Tezacaftor/Ivacaftor in patients with cystic fibrosis and advanced lung disease
O'Carroll, O. M.
O'Shea, K. M.
Carroll, C.
Grogan, B.
Connolly, A.
O'Shaughnessy, L.
Nicholson, T.
Gallagher, C. G.
McKone, E. F.
IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (SUPPL 1) : S16 - S16
[7] Efficacy of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease
O'Shea, Kate M.
O'Carroll, Orla M.
Carroll, Catherine
Grogan, Brenda
Connolly, Anna
O'Shaughnessy, Lynda
Nicholson, Trevor T.
Gallagher, Charles G.
McKone, Edward F.
EUROPEAN RESPIRATORY JOURNAL, 2021, 57 (02)
[8] Effects of elexacaftor-tezacaftor-ivacaftor discontinuation in cystic fibrosis
Mitropoulou, Georgia
Balmpouzis, Zisis
Polojoux, Jerome
Dotta-Celio, Jennifer
Sauty, Alain
Koutsokera, Angela
RESPIRATORY MEDICINE AND RESEARCH, 2022, 82
[9] Ivacaftor-elexacaftor-tezacaftor and tacrolimus combination in cystic fibrosis
Smith, Megan
Ryan, Kevin J.
Gutierrez, Hector
Sanchez, Luz Helena Gutierrez
Anderson, Janaina Nogueira
Acosta, Edward P.
Benner, Kim W.
Guimbellot, Jennifer S.
JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (01) : E8 - E10
[10] Impact of elexacaftor/tezacaftor/ivacaftor on depression and anxiety in cystic fibrosis
Zhang, Lijia
Albon, Dana
Jones, Marieke
Bruschwein, Heather
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16

← 1 2 3 4 5 →